Porton Advanced and NovaCell Therapeutics Announced Strategic Cooperation to Accelerate NK Cell Therapy Development
Porton Advanced’s End-to-End Bacterial Vector CDMO Solution Accelerates FDA Approval of Salvectors’ Innovative Oncolytic Bacteria Therapy
Porton Advanced’s Comprehensive CDMO Solutions Facilitates Qihan Biotech with FDA Clearance of IND application of its First-in-Class Universal Dual-Targeting CAR-T Cell Therapy
Porton Advanced and CellStore Partner to Optimize Cryopreservation Media for More Affordable Cell Therapies
Porton Advanced and EVA Pharma Sign MOU to Expand CAR T-Cell Therapy Access in The Middle East and Africa
Porton Advanced Announces Collaboration with TongEYE to Accelerate Development of iPSC-RPEC transplantation therapy
